Man Group PLC Precision Biosciences Inc Transaction History

Man Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.97 - $45.0 $96,036 - $4.46 Million	-99,007 Reduced 80.98%	23,256 $27,000
Q3 2022 Nov 14, 2022	BUY	$1.22 - $40.8 $149,160 - $4.99 Million	122,263 New	122,263 $159,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $23,899 - $69,411	-20,782 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.96 - $7.76 $61,514 - $161,268	20,782 New	20,782 $64,000
Q1 2021 May 17, 2021	SELL	$8.57 - $15.79 $508,201 - $936,347	-59,300 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.98 - $12.47 $94,484 - $197,026	-15,800 Reduced 21.04%	59,300 $495,000
Q3 2020 Nov 16, 2020	BUY	$4.65 - $8.73 $190,933 - $358,462	41,061 Added 120.63%	75,100 $463,000
Q2 2020 Aug 14, 2020	BUY	$4.66 - $8.7 $158,621 - $296,139	34,039 New	34,039 $284,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $526M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.